Skip to main content
AAN.com
Articles
March 3, 2010

Herpes zoster ophthalmicus and the risk of stroke
A population-based follow-up study

March 9, 2010 issue
74 (10) 792-797

Abstract

Objective: To investigate the risk of stroke development following a diagnosis of herpes zoster ophthalmicus (HZO).
Methods: Data were retrospectively collected from the Taiwan National Health Insurance Research Database. The study cohort comprised all patients with a diagnosis of HZO (ICD-9-CM code 053.2) in 2003 and 2004 (n = 658). The comparison cohort was comprised of randomly selected patients (3 for every HZO patient, n = 1974) matched with the study group in terms of age and gender. Patients were tracked from their index visits for 1 year. The Kaplan-Meier method was utilized to compute the 1-year stroke-free survival rate. Cox proportional hazard regressions were carried out to compute the adjusted 1-year stroke-free survival rate after adjusting for possible confounding factors.
Results: Stroke developed in 8.1% of patients with HZO and 1.7% of patients in the comparison cohort during the 1-year follow-up period. HZO patients had significantly lower 1-year stroke-free survival rates than patients in the comparison cohort. After adjusting for patients' demographic characteristics, selected comorbidities, and medication habits, HZO patients were found to have a 4.52-fold (95% confidence interval 2.45–8.33) higher risk of stroke than the matched comparison cohort. There was no significant difference in the rate of stroke development between patients who had received systemic antiviral treatment and those who had not.
Conclusions: Herpes zoster ophthalmicus may represent a marker of increased risk of stroke development during the 1-year follow-up period.

Get full access to this article

View all available purchase options and get full access to this article.

REFERENCES

1.
Arvin AM. Varicella-zoster virus. Clin Microbiol Rev 1996;9:361–381.
2.
Gilden DH, Cohrs RJ, Mahalingam R. Clinical and molecular pathogenesis of varicella virus infection. Viral Immunol 2003;16:243–258.
3.
Mueller NH, Gilden DH, Cohrs RJ, Mahalingam R, Nagel MA. Varicella zoster virus infection: clinical features, molecular pathogenesis of disease, and latency. Neurol Clin 2008;26:675–697.
4.
Shaikh S, Ta CN. Evaluation and management of herpes zoster ophthalmicus. Am Fam Physician 2002;66:1723–1730.
5.
Ragozzino MW, Melton LJ III, Kurland LT, et al. Population-based study of herpes zoster and its sequelae. Medicine 1982;61:310–316.
6.
Womack LW, Liesegang TJ. Complications of herpes zoster ophthalmicus. Arch Ophthalmol 1983;101:42–45.
7.
Gilden DH, Kleinschmidt-DeMasters BK, LaGuardia JJ, Mahalingam R, Cohrs RJ. Neurologic complications of the reactivation of varicella-zoster virus. N Engl J Med 2000;342:635–645.
8.
Kennedy PG. Varicella-zoster virus latency in human ganglia. Rev Med Virol 2002;12:327–334.
9.
Askalan R, Laughlin S, Mayank S, et al. Chickenpox and stroke in childhood: a study of frequency and causation. Stroke 2001;32:1257–1262.
10.
Gilbert GJ. Herpes zoster ophthalmicus and delayed contralateral hemiparesis: relationship of the syndrome to central nervous system granulomatous angiitis. JAMA 1974;229:302–324.
11.
Kuroiwa Y, Furukawa T. Hemispheric infarction after herpes zoster ophthalmicus: computed tomography and angiography. Neurology 1981;31:1030–1032.
12.
Elble RJ. Intracerebral hemorrhage with herpes zoster ophthalmicus. Ann Neurol 1983;14:591–592.
13.
Hilt DC, Buchholz D, Krumholz A, Weiss H, Wolinsky JS. Herpes zoster ophthalmicus and delayed contralateral hemiparesis caused by cerebral angiitis: diagnosis and management approaches. Ann Neurol 1983;14:543–553.
14.
Reshef E, Greenberg SB, Jankovic J. Herpes zoster ophthalmicus followed by contralateral hemiparesis: report of two cases and review of literature. J Neurol Neurosurg Psychiatry 1985;48:122–127.
15.
Mpaka M, Karantanas AH, Zakynthinos E. Atypical presentation of varicella-zoster virus encephalitis in an immunocompetent adult. Heart Lung 2008;37:61–66.
16.
Joy JL, Colon HF, Velez-Borras JR. The syndrome of cerebral infarction following herpes zoster ophthalmicus. Bol Assoc Med P R 1989;81:24–25.
17.
Sarazin L, Duong H, Bourgouin PM, et al. Herpes zoster vasculitis: demonstration by MR angiography. J Comput Assist Tomogr 1995;19:624–627.
18.
Cadavid D, Pearl PL, Dubovsky EC, Angiolillo A, Vezina LG. Stroke after zoster ophthalmicus in a 12-year-old girl with protein C deficiency. Neurology 1999;53:1128–1129.
19.
Moriuchi H, Rodriguez W. Role of varicella-zoster virus in stroke syndromes. Pediatr Infect Dis J 2000;19:648–653.
20.
Nogueira RG, Sheen VL. Images in clinical medicine: herpes zoster ophthalmicus followed by contralateral hemiparesis. N Engl J Med 2002;346:1127.
21.
Nagel MA, Cohrs RJ, Mahalingam R, et al. The varicella zoster virus vasculopathies: clinical, CSF, imaging, and virologic features. Neurology 2008;70:853–860.
22.
Melanson M, Chalk C, Georgevich L, et al. Varicella-zoster virus DNA in CSF and arteries in delayed contralateral hemiplegia: evidence for viral invasion of cerebral arteries. Neurology 1996;47:569–570.
23.
Gilden D. The ever-widening spectrum of varicella zoster virus vasculopathy. Eur J Neurol 2008;15:e88–e89.
24.
Verghese A, Sugar AM. Herpes zoster ophthalmicus and granulomatous angiitis: an ill-appreciated cause of stroke. J Am Geriatr Soc 1986;34:309–312.
25.
Ibrahim AI, Obeid MT, Jouma MJ, et al. Detection of herpes simplex virus, cytomegalovirus and Epstein-Barr virus DNA in atherosclerotic plaques and in unaffected bypass grafts. J Clin Virol 2005;32:29–32.
26.
Shi Y, Tokunaga O. Herpesvirus (HSV-1, EBV and CMV) infections in atherosclerotic compared with non-atherosclerotic aortic tissue. Pathol Int 2002;52: 31–39.
27.
Kher N, Marsh JD. Pathobiology of atherosclerosis–a brief review. Semin Thromb Hemost 2004;30:665–672.
28.
Pavan-Langston D. Herpes zoster antivirals and pain management. Ophthalmology 2008;115:S13–S20.
29.
Kang JH, Ho JD, Chen YH, et al. Increased risk of stroke after herpes zoster attack: a population-based follow-up. Stroke Epub 2009 Oct 15.
30.
Data from Directorate-General of Budget, Accounting and Statistics, Executive Yuan, Republic of China (Taiwan). Available at: http://www.stat.gov.tw/public/Attachment/511171894671.xls. Accessed September 15, 2009.

Information & Authors

Information

Published In

Neurology®
Volume 74Number 10March 9, 2010
Pages: 792-797
PubMed: 20200348

Publication History

Published online: March 3, 2010
Published in print: March 9, 2010

Permissions

Request permissions for this article.

Notes

Authors

Affiliations & Disclosures

Herng-Ching Lin, PhD
From the School of Health Care Administration (H.-C.L.) and Department of Ophthalmology (J.-D.H.), Taipei Medical University, Taipei; Institute of Hospital and Health Care Administration (C.-W.C.), National Yang-Ming University, Taipei; and Department of Ophthalmology (J.-D.H.), Taipei Medical University Hospital, Taipei, Taiwan.
Ching-Wen Chien, PhD
From the School of Health Care Administration (H.-C.L.) and Department of Ophthalmology (J.-D.H.), Taipei Medical University, Taipei; Institute of Hospital and Health Care Administration (C.-W.C.), National Yang-Ming University, Taipei; and Department of Ophthalmology (J.-D.H.), Taipei Medical University Hospital, Taipei, Taiwan.
Jau-Der Ho, MD, PhD
From the School of Health Care Administration (H.-C.L.) and Department of Ophthalmology (J.-D.H.), Taipei Medical University, Taipei; Institute of Hospital and Health Care Administration (C.-W.C.), National Yang-Ming University, Taipei; and Department of Ophthalmology (J.-D.H.), Taipei Medical University Hospital, Taipei, Taiwan.

Notes

Address correspondence and reprint requests to Dr. Jau-Der Ho, Department of Ophthalmology, Taipei Medical University Hospital, 252 Wu-Hsing Street, Taipei 110, Taiwan [email protected]

Metrics & Citations

Metrics

Citation information is sourced from Crossref Cited-by service.

Citations

Download Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Select your manager software from the list below and click Download.

Cited By
  1. Varicella-Zoster Meningitis and Myelitis After Herpes Zoster Dermatitis Treatment With Amenamevir: A Case Series and Literature Review, Cureus, (2024).https://doi.org/10.7759/cureus.54775
    Crossref
  2. A case of a young woman with bilateral medial medullary infarcts caused by varicella-zoster virus vasculopathy without skin rash皮疹を伴わない水痘-帯状疱疹ウィルス血管症によって両側延髄内側梗塞を呈した若年女性の1例, Rinsho Shinkeigaku, 64, 8, (583-588), (2024).https://doi.org/10.5692/clinicalneurol.cn-001973
    Crossref
  3. Herpes Zoster and Cardiovascular Disease: Exploring Associations and Preventive Measures through Vaccination, Vaccines, 12, 3, (252), (2024).https://doi.org/10.3390/vaccines12030252
    Crossref
  4. Use of antiviral drugs and incidence of Parkinson’s disease in Taiwan, PLOS ONE, 19, 5, (e0302383), (2024).https://doi.org/10.1371/journal.pone.0302383
    Crossref
  5. Varicella zoster vasculopathy causing recurrent ischaemic strokes in an immunocompetent patient, Practical Neurology, (pn-2024-004335), (2024).https://doi.org/10.1136/pn-2024-004335
    Crossref
  6. Expanded spectrum of varicella disease and the need for vaccination in India, Human Vaccines & Immunotherapeutics, 20, 1, (2024).https://doi.org/10.1080/21645515.2024.2328955
    Crossref
  7. Herpes zoster ophthalmicus, Clinics in Dermatology, 42, 4, (355-359), (2024).https://doi.org/10.1016/j.clindermatol.2024.01.007
    Crossref
  8. Lying in Wait—Stroke and a Blistering Rash, Stroke Medicine, (181-189), (2024).https://doi.org/10.1007/978-3-031-58188-5_23
    Crossref
  9. A comprehensive, updated systematic review and meta‐analysis of epidemiologic evidence on the connection between herpes zoster infection and the risk of stroke, Reviews in Medical Virology, 34, 4, (2024).https://doi.org/10.1002/rmv.2556
    Crossref
  10. Risk of dementia following herpes zoster infection among patients undertreatment versus those not: A systematic review and meta‐analysis, Health Science Reports, 7, 3, (2024).https://doi.org/10.1002/hsr2.1941
    Crossref
  11. See more
Loading...

View Options

Login options

Check if you have access through your login credentials or your institution to get full access on this article.

Personal login Institutional Login
Purchase Options

The neurology.org payment platform is currently offline. Our technical team is working as quickly as possible to restore service.

If you need immediate support or to place an order, please call or email customer service:

  • 1-800-638-3030 for U.S. customers - 8:30 - 7 pm ET (M-F)
  • 1-301-223-2300 for customers outside the U.S. - 8:30 - 7 pm ET (M-F)
  • [email protected]

We appreciate your patience during this time and apologize for any inconvenience.

View options

PDF and All Supplements

Download PDF and Supplementary Material

Full Text

View Full Text

Full Text HTML

View Full Text HTML

Media

Figures

Other

Tables

Share

Share

Share article link

Share